# REDEMPLO

NDC: 84141-025
Generic name: plozasiran
Labeler / Manufacturer: Arrowhead Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20251119

FDA application: NDA219947

## Active ingredients

- PLOZASIRAN: 25 mg/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"84141-025"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=84141-025
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7fd37993-f85a-4af1-8bbe-133299f226ed